Immutep Limited (IMMP)
Nasdaq: IMMP · Pharmaceutical Preparations · Sydney,, AU · filing with the SEC since 2012
Who runs Immutep Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Voigt Marc
Chief Executive Officer, Chief Financial Officer, Executive Director. First filing Apr 2026, latest Apr 13, 2026, 0 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
8 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Voigt Marc | Chief Executive Officer, Chief Financial Officer, Executive Director | Apr 2026 | Apr 13, 2026 | none |
| Miller Deanne Diem | Chief Operating Officer | Apr 2026 | Apr 13, 2026 | none |
| Mueller Christian | Chief Development Officer | Apr 2026 | Apr 1, 2026 | none |
| Winckels Stephan Karel Gerard | Chief Medical Officer | Apr 2026 | Apr 1, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Boyce Elisabeth Amanda | director | Apr 2026 | Apr 16, 2026 | none |
| Meyers Pete A. | director | Apr 2026 | Apr 7, 2026 | none |
| Howard Russell J | director | Apr 2026 | Apr 1, 2026 | none |
| Triebel Frederic Joseph Daniel | director | Apr 2026 | Apr 1, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.